Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the …
PG Northup, JC Garcia‐Pagan, G Garcia‐Tsao… - …, 2021 - Wiley Online Library
• An overview of the current understanding of bleeding and thrombosis in cirrhosis.• An
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
evidence-based justification for bleeding risk assessment in patients with cirrhosis before …
AGA clinical practice update: coagulation in cirrhosis
JG O'Leary, CS Greenberg, HM Patton, SH Caldwell - Gastroenterology, 2019 - Elsevier
Description This expert review was commissioned and approved by the AGA Institute
Clinical Practice Updates Committee and the AGA Governing Board to provide timely …
Clinical Practice Updates Committee and the AGA Governing Board to provide timely …
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
poses several difficult clinical questions. These Clinical Practice Guidelines have been …
[PDF][PDF] Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial
L De Pietri, M Bianchini, R Montalti, N De Maria… - …, 2016 - Wiley Online Library
Bleeding is a feared complication of invasive procedures in patients with cirrhosis and
significant coagulopathy (as defined by routine coagulation tests) and is used to justify …
significant coagulopathy (as defined by routine coagulation tests) and is used to justify …
The coagulopathy of chronic liver disease
A Tripodi, PM Mannucci - New England Journal of Medicine, 2011 - Mass Medical Soc
The Coagulopathy of Chronic Liver Disease | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy
MJ McConnell, N Kawaguchi, R Kondo, A Sonzogni… - Journal of …, 2021 - Elsevier
Background and Aims COVID-19 is associated with liver injury and elevated interleukin-6 (IL-
6). We hypothesized that IL-6 trans-signaling in liver sinusoidal endothelial cells (LSECs) …
6). We hypothesized that IL-6 trans-signaling in liver sinusoidal endothelial cells (LSECs) …
ACG clinical guideline: disorders of the hepatic and mesenteric circulation
Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries
have important clinical consequences and may lead to acute liver failure, chronic liver …
have important clinical consequences and may lead to acute liver failure, chronic liver …
[HTML][HTML] The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients …
T Lisman, V Hernandez‐Gea, M Magnusson… - Journal of Thrombosis …, 2021 - Elsevier
Patients with liver diseases acquire complex alterations in their hemostatic system that may
lead to abnormalities in routine diagnostic test of hemostasis. Thrombocytopenia …
lead to abnormalities in routine diagnostic test of hemostasis. Thrombocytopenia …
[HTML][HTML] Haemostatic alterations and management of haemostasis in patients with cirrhosis
T Lisman, SH Caldwell, NM Intagliata - Journal of Hepatology, 2022 - Elsevier
Patients with cirrhosis frequently acquire complex changes in their haemostatic system
including a decreased platelet count and decreased levels of various haemostatic proteins …
including a decreased platelet count and decreased levels of various haemostatic proteins …
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death
A Zanetto, E Campello, C Bulato, S Gavasso… - Journal of …, 2022 - Elsevier
Background & Aims Studies on platelet aggregation in cirrhosis are controversial because
interpretation of platelet function is challenged by thrombocytopenia. We conducted a …
interpretation of platelet function is challenged by thrombocytopenia. We conducted a …